Rick Vreman
17PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (17)
Sort by Publication Date:
|Mar 20, 2024
Agreement about Availability of Alternative Treatments for Innovative Drugs Assessed by the EMA and HTA Organizations.Jorge Madrid Paredes, Jan-Willem Versteeg, Rick A Vreman
|Dec 18, 2023
Response to uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group - author's reply.Milou Amber Hogervorst, Rick Vreman, Inkatuuli Heikkinen
|Jun 16, 2023
Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group.Milou Amber Hogervorst, Rick Vreman, Inkatuuli Heikkinen
|Jun 15, 2023
The Beneluxa Initiative domain task force health technology assessment: a comparison of member countries' past health technology assessments.Rick A Vreman, Daan van Hoof, Anna Nachtnebel
|Jan 08, 2023
When Reality Does Not Meet Expectations-Experiences and Perceived Attitudes of Dutch Stakeholders Regarding Payment and Reimbursement Models for High-Priced Hospital Drugs.Marcelien H E Callenbach, Rick A Vreman, Aukje K Mantel-Teeuwisse
|Jan 31, 2022
Addressing uncertainty in relative effectiveness assessments by HTA organizations.Rick A Vreman, George Strigkos, Hubert G M Leufkens
Pageof 3
Frequent Collaborators
5 joint publications
Wim Goettsch
4 joint publications
Aukje K Mantel-Teeuwisse
2 joint publications
Wija Oortwijn
2 joint publications
Lourens T Bloem
2 joint publications
Inkatuuli Heikkinen
2 joint publications
Hans-Georg Eichler
2 joint publications
Milou Amber Hogervorst
1 joint publications
Huseyin Naci
1 joint publications
Hubert G M Leufkens
1 joint publications
Rachel R J Kalf
